Tag - APTN

By Melane Sampson Michael J. Roberts, PhD, CEO and Co-founder of Adaptin Bio Adaptin Bio (OTCQB: APTN) is advancing a novel strategy to overcome one of the most persistent challenges in neuro-oncology—delivering...